Skip to content
HowShorted

Compass Therapeutics, Inc. short interest in 2024

In 2024, Compass Therapeutics, Inc.'s disclosed short interest ran from 1.56% of shares outstanding on 12 Jan 2024 to 1.61% on 31 Dec 2024, a change of +0.05 percentage points. The year's high was 1.81% on 30 Sep 2024 and its low 0.89% on 15 Nov 2024, averaging 1.37% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.41 days on 31 May 2024. Full history: Compass Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Compass Therapeutics, Inc. in 2024

2024 in figures

Start of year
1.56% (12 Jan 2024)
End of year
1.61% (31 Dec 2024)
Change
+0.05 pp
High
1.81% (30 Sep 2024)
Low
0.89% (15 Nov 2024)
Average
1.37%
Highest days to cover
9.41 (31 May 2024)
SEC filings marked
9

Every report in 2024

Compass Therapeutics, Inc. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 20241.56%1.64results (8-K)
31 Jan 20241.71%6.18
15 Feb 20241.55%5.09
29 Feb 20241.44%3.55
15 Mar 20241.37%5.76
28 Mar 20241.18%5.0210-K filed, results (8-K)
15 Apr 20241.18%3.67
30 Apr 20241.19%7.73
15 May 20241.19%5.0710-Q filed, results (8-K)
31 May 20241.13%9.41
14 Jun 20241.15%4.67
28 Jun 20241.32%2.75
15 Jul 20241.47%5.85
31 Jul 20241.37%5.50
15 Aug 20241.30%3.3610-Q filed, results (8-K)
30 Aug 20241.35%5.67
13 Sep 20241.67%5.61
30 Sep 20241.81%5.12
15 Oct 20241.60%4.99
31 Oct 20241.30%3.51
15 Nov 20240.89%2.0410-Q filed, results (8-K)
29 Nov 20241.06%2.94
13 Dec 20241.53%5.03
31 Dec 20241.61%6.64

See also: Compass Therapeutics, Inc.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.